| Company Name: |
Tianjin Kailiqi Biotechnology Co., Ltd.
|
| Tel: |
15076683720 |
| Email: |
klq@cw-bio.com |
| Products Intro: |
Product Name:Heptamidine CAS:94345-47-8 Purity:≥98% Package:100mg 1g,5g,根據(jù)客戶需要分裝 Remarks:Not For Human Use, Lab Use Only.
|
| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:Heptamidine CAS:94345-47-8 Purity:>98% Package:1mg;10mg;50mg;100mg;
|
4-[7-(4-carbamimidoylphenoxy)heptoxy]benzenecarboximidamide manufacturers
- Heptamidine
-
- $2500.00
-
2026-04-20
- CAS:94345-47-8
- Purity:
- Supply Ability: 10g
- Heptamidine
-
- $2500.00
-
2025-07-21
- CAS:94345-47-8
- Purity:
- Supply Ability: 10g
|
| | 4-[7-(4-carbamimidoylphenoxy)heptoxy]benzenecarboximidamide Basic information |
| | 4-[7-(4-carbamimidoylphenoxy)heptoxy]benzenecarboximidamide Chemical Properties |
| Melting point | 175-177 °C (decomp) | | Boiling point | 558.0±60.0 °C(Predicted) | | density | 1.17±0.1 g/cm3(Predicted) | | pka | 12.81±0.50(Predicted) |
| | 4-[7-(4-carbamimidoylphenoxy)heptoxy]benzenecarboximidamide Usage And Synthesis |
| Uses | Heptamidine (SBi4211) is a potent Pentamidine-related inhibitor of the calcium-binding protein S100B (Kd=6.9 μM), selectively kills melanoma cells with S100B over those without S100B[1]. Heptamidine is a useful tool for the investigation of Myotonic dystrophy (DM)[2]. | | in vivo | Heptamidine (intraperitoneal injection; 20 or 30 mg/kg; 7 days) causes a dose-dependent reduction of exon 7a inclusion inHSALRmice, returning to wild type levels (6±1%) when at 20 mg/kg dose, the myotonia is reduced from grade 3 to grade 1 (occasional myotonic discharge) or grade 0 at both 20 or 30 mg/kg[2]. | Animal Model: | HomozygousHSALRtransgenic mice in line 20b (FVB inbred background)with a Myotonic dystrophy (DM) mouse model[2] | | Dosage: | 20 or 30 mg/kg | | Administration: | Intraperitoneal injection; 7 days; once daily | | Result: | Reversed splicing defects and rescues myotonia in a DM mouse model. |
| | References | [1] McKnight LE, et al. Structure-Based Discovery of a Novel Pentamidine-Related Inhibitor of the Calcium-Binding Protein S100B. ACS Med Chem Lett.2012Dec 13;3(12):975-979. Epub2012Sep 25. DOI:10.1021/ml300166s [2] Coonrod LA, et al. Reducing levels of toxic RNA with small molecules.ACS Chem Biol.2013 Nov 15;8(11):2528-37. DOI:10.1021/cb400431f |
| | 4-[7-(4-carbamimidoylphenoxy)heptoxy]benzenecarboximidamide Preparation Products And Raw materials |
|